Healthium Medtech, a global medical technology company with a rapidly expanding portfolio across surgical, post-surgical, advanced wound care, arthroscopy, and infection prevention, has announced an exclusive partnership with US-based Tisgenx, a world leader in the manufacturing of bovine pericardial tissue patches.

These advanced tissue patches, widely used in valve repair, vessel reconstruction, and other complex cardiovascular and soft tissue interventions, will now be available to Indian surgeons through this strategic collaboration. Under the agreement, Healthium has secured exclusive rights to distribute Tisgenx’s products in India.

This partnership marks a significant step in strengthening Healthium’s position in the cardiac care segment and underscores its commitment to innovation-driven, specialty-focused healthcare solutions. The addition of Tisgenx’s high-quality pericardial tissue patches complements Healthium’s mission to provide surgeon-centric innovations that enhance clinical decision-making and improve patient outcomes.

Commenting on the partnership, Anish Bafna, CEO & Managing Director of Healthium Medtech, said, “We are proud to bring Tisgenx’s globally trusted pericardial tissue patches to India through this exclusive partnership. As a homegrown medtech company, Healthium remains committed to delivering world-class solutions that address the evolving needs of Indian surgeons and empower them to provide the best possible care for their patients.”

Kris Kupumbati, CEO & President of Tisgenx, added, “India is one of the fastest-growing healthcare markets in the world, and this collaboration with Healthium allows us to play a meaningful role in advancing cardiac care across the region. Together, we are expanding access to global innovations while upholding our shared commitment to surgeon-centric and patient-first solutions.”

This partnership further reflects Healthium’s ongoing efforts to strengthen the Indian medtech ecosystem by enabling greater access to global technologies and innovations. It reinforces the company’s dedication to enhancing the broader surgical care landscape through advanced, reliable, and clinically relevant solutions tailored to local healthcare needs.